Showing results (801-810 of 964) with videos related to
Sort By:
Pageof 97
Proceedings of the National Academy of Sciences of the United States of America|November 5, 2008
Genome-wide assessment of worldwide chicken SNP genetic diversity indicates significant absence of rare alleles in commercial breedsWilliam M Muir, Gane Ka-Shu Wong, Yong Zhang, et al.Allergy|September 3, 2011
Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trialW J Videler, L Badia, R J Harvey, et al.The Lancet. Gastroenterology & Hepatology|June 26, 2020
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statementGrace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, et al.Clinical Transplantation|December 13, 2023
Impact of Share 35 liver transplantation allocation in Australia and New ZealandMichael A Fink, Paul J Gow, Geoffrey W McCaughan, et al.Journal of Hepatology|May 23, 2021
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infectionGail V Matthews, Sanjay Bhagani, Marc Van der Valk, et al.Genome Research|May 9, 2002
RePS: a sequence assembler that masks exact repeats identified from the shotgun dataJun Wang, Gane Ka-Shu Wong, Peixiang Ni, et al.The New England Journal of Medicine|September 26, 2025
Nexiguran Ziclumeran Gene Editing in Hereditary ATTR with PolyneuropathyJulian D Gillmore, Ed Gane, Jörg Täubel, et al.Antiviral Therapy|July 16, 2020
Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjectsMaribel Reyes, Justin D Lutz, Audrey H Lau, et al.Hepatology (Baltimore, Md.)|October 15, 2014
Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virusEric M Yoshida, Mark S Sulkowski, Edward J Gane, et al.Gigascience|October 24, 2019
Access to RNA-sequencing data from 1,173 plant species: The 1000 Plant transcriptomes initiative (1KP)Eric J Carpenter, Naim Matasci, Saravanaraj Ayyampalayam, et al.Pageof 97